Anti-HIV IgA isotypes
Scale-up of combination prevention and antiretroviral therapy for female sex workers in West Africa
HIV exposed seronegative individuals show antibodies specifically recognizing native HIV envelope glycoprotein
Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection
Vitamin D attenuates nucleoside reverse transcriptase inhibitor induced human skeletal muscle mitochondria DNA depletion
Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy
Differential penetration of raltegravir throughout gastrointestinal tissue
Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteers
Predicting risk of cancer during HIV infection
Tenofovir-based combination therapy for HIV/HBV co-infection
Positive impact of a large-scale HIV prevention programme among female sex workers and clients in South India
Outcomes of home visits for pregnant mothers and their infants
Association of HIV clinical disease progression with profiles of early immune activation
Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings
Evaluation of impact of long-lasting insecticide-treated bed nets and point-of-use water filters on HIV-1 disease progression in Kenya
GPS-measured distance to clinic, but not self-reported transportation factors, are associated with missed HIV clinic visits in rural Uganda
Viral load monitoring for antiretroviral therapy in resource-poor settings
The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults
Treatment-related changes in serum lipids and inflammation
HIV replication, inflammation and atherogenesis
Enforcing the law to obtain an HIV test in a minor
Rapid, complex adaptation of transmitted HIV-1 full-length genomes in subtype C-infected individuals with differing disease progression
T-bet is overexpressed in the CD4+ T cells of HIV Controllers